The North America radiopharmaceutical theranostics market size is expected to grow from US$ 795.88 million in 2022 to US$ 1,529.88 million by 2028; it is estimated to record a CAGR of 11.5% from 2022 to 2028.
The North America radiopharmaceutical theranostics market is segmented on the basis of product type, radioisotope, source, application, indication, end user, and country. The report offers insights and in-depth analysis of the market, emphasizing parameters such as dynamics, trends, and opportunities prevailing in the market. It also provides the competitive landscape analysis of leading market players in North America.
Market Insights
Rising Application in Treatment of Cardiovascular Disorders Drives North America Radiopharmaceutical Theranostics Market Growth
Atherosclerosis remains a dominant cause of cardiovascular diseases (CVDs). It acts as a life-threatening CVD resulting in chronic inflammation and abnormal lipid proliferation, and it is often difficult to treat on time due to the lack of noticeable symptoms in the initial phases. Due to their associated complexity and pathophysiology, CVDs have been presenting major challenges to healthcare systems in North American countries. Per the 2022 report by the Centers for Disease Control and Prevention (CDC), heart disease is a leading cause of death among men and women in the US. It was a cause of ~697,000 deaths, i.e., 1 in 5 deaths, in the US in 2020. A National Institute of Health (NIH) report states that theranostic nanoparticles have gained significant attention in the medical field, as the techniques help overcome complexities and pathophysiological complications associated with CVDs. Cardiovascular imaging of atherosclerosis patients provides pathophysiological evidence that can be used to treat these diseases. Further, theranostic nanoparticles can be combined with a range of imaging techniques, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT). Various clinical research studies have been conducted in clinical laboratories so far. A three-in-one therapeutic complex has been constructed by combining a polymeric photoacoustic probe with nanoparticles-PLCDP@PMH. Clinical in-vivo evaluations reveal that the PLCDP@PMH supports the theranostics approach by enabling early-stage atherosclerosis detection in patients.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
North America Radiopharmaceutical Theranostics Market: Strategic Insights
Market Size Value in US$ 795.88 million in 2022 Market Size Value by US$ 1,529.88 million by 2028 Growth rate CAGR of 11.5% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
North America Radiopharmaceutical Theranostics Market: Strategic Insights
| Market Size Value in | US$ 795.88 million in 2022 |
| Market Size Value by | US$ 1,529.88 million by 2028 |
| Growth rate | CAGR of 11.5% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Product Type-Based Insights
Based on product type, the North America radiopharmaceutical theranostics market is segmented into positron emission tomography (PET) tracers, beta emitters, and alpha emitters. In 2022, the positron emission tomography (PET) tracers segment held the largest share of the market, and it is anticipated to register the highest CAGR during the forecast period.
North America Radiopharmaceutical Theranostics Market, by Product Type – 2022–2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Radioisotope-Based Insights
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on radioisotope, the North America radiopharmaceutical theranostics market is divided into Lutetium (Lu) 177, Gallium-68, Iodine-131, Iodine-123, Technetium-99, Yttrium-90 (Y-90), Copper (Cu) 64, 18F, Copper (Cu) 67, and others. In 2022, the Lutetium (Lu) 177 segment held the largest share of the market and is anticipated to register the highest CAGR during the forecast period.
Source-Based Insights
Based on source, the North America radiopharmaceutical theranostics market is bifurcated into cyclotrons and nuclear reactors. The cyclotrons segment held a larger share of the market in 2022, and it is expected to record at a higher CAGR during the forecast period.
Application-Based Insights
Based on application, the North America radiopharmaceutical theranostics market is bifurcated into targeted therapeutic (Rx) and companion diagnostic (CDx). In 2022, the targeted therapeutic (Rx) segment held a larger share of the market, and it is anticipated to register a higher CAGR during the forecast period.
Indication-Based Insights
Based on indication, the North America radiopharmaceutical theranostics market is segmented into oncology, neurology, cardiology, and others. The oncology segment held the largest share of the market in 2022, and it is anticipated to register the highest CAGR during the forecast period.
End User-Based Insights
Based on end user, the North America radiopharmaceutical theranostics market is segmented into hospitals, diagnostic imaging centers, academic and research institutes, and others. The hospitals segment held the largest market share in 2022. However, the academic and research institutes segment is anticipated to register the highest CAGR during the forecast period. Hospitals employ technologically advanced systems to treat cardiac aneurysms, neurology aneurysms, oncology tumors, and other similar conditions. The rising prevalence of various diseases and an increasing number of hospitals contribute to the growth of the market for hospitals segment.
The North America radiopharmaceutical theranostics market players adopt organic strategies, such as product launch and expansion, to expand their footprint and product portfolio and meet growing demands. Inorganic growth strategies witnessed in the market are partnerships and collaborations. These growth strategies have allowed the market players to expand their businesses and enhance their geographic presence. Additionally, acquisitions, partnerships, and other growth strategies help them strengthen their customer base.
- In October 2022, Telix received Health Canada approval for its Illuccix, a kit for the preparation of gallium (68Ga) gozetotide injection. The product can be used in staging and re-staging intermediate and high-risk prostate cancer and localizing tumor tissue in recurrent prostate cancer. Illuccix was the first PSMA PET imaging agent that was granted regulatory approval in Canada. Health Canada was the third regulatory body worldwide to approve Illuccix, which is commercially available in Australia and the US.
- In December 2021, GE Healthcare and Minerva Imaging entered in a strategic partnership to accelerate the commercial launch of targeted radionuclide therapies (theranostics). Radionuclide therapy is a form of precision medicine where a radioactive substance is administered through the bloodstream to target cancer cells and irradiate them specifically. This helps reduce potential side effects compared to traditional cancer therapies.
Company Profiles
- Bayer AG
- GE HealthCare Technologies Inc
- Curium
- Lantheus Medical Imaging, Inc.
- Telix Pharmaceuticals Ltd.
- Cardinal Health Inc
- Advanced Accelerator Applications S.A.
- Jubilant Radiopharma
- Theragnostics
- NuView Life Sciences
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Radioisotope, Source, Application, Indication, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Radiopharmaceuticals are radioisotopes that are bound to biological molecules that target specific tissues, organs, or cells within the human body. Radioisotopes emitting gamma rays are useful for diagnostic imaging where the radiation escapes the body. Nuclear medicine imaging generally utilizes radioactive isotopes attached to specific molecules to examine biological processes, such as disease pathophysiology. Every radiopharmaceutical is designed to travel to a specific location in the body, and as soon as it reaches the site, it releases radioactive substances that kill the tumor cells. Radiopharmaceuticals can target various malignancies such as prostate cancer, heart disease, thyroid cancer, and others. These drugs can also be used as both therapies and diagnostics, known as 'theranostics’. In theranostics, radiopharmaceuticals are used for therapeutic and diagnostic purposes by targeting one specific tumor receptor.
Rising incidence of cancer and rising application in treatment of cardiovascular disorders are the most significant factors responsible for the overall market growth.
Based on product type, the Positron Emission Tomography (PET) tracers segment held the largest share of the market and is expected to grow at the fastest rate during the coming years.
Based on the application, the targeted therapeutic (Rx) segment held the largest share of the market and is expected to grow at the fastest rate during the coming years.
The hospitals segment dominated the radiopharmaceutical theranostics market and accounted for the largest market share in 2022.
Bayer AG; GE HealthCare Technologies Inc; Curium; Lantheus Medical Imaging, Inc.; Telix Pharmaceuticals Ltd.; Cardinal Health Inc; Advanced Accelerator Applications S.A.; Jubilant Radiopharma; Theragnostics; and NuView Life Sciences are among the leading companies operating in the radiopharmaceutical theranostics market.
Radiopharmaceutical theranostics market is segmented by countries comprising of US, Canada, and Mexico.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Radiopharmaceutical Theranostics Market – by Product Type
1.3.2 North America Radiopharmaceutical Theranostics Market – by Radioisotope
1.3.3 North America Radiopharmaceutical Theranostics Market – by Source
1.3.4 North America Radiopharmaceutical Theranostics Market – by Application
1.3.5 North America Radiopharmaceutical Theranostics Market – by Indication
1.3.6 North America Radiopharmaceutical Theranostics Market – by End User
1.3.7 North America Radiopharmaceutical Theranostics Market – by Country
2. North America Radiopharmaceutical Theranostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Radiopharmaceutical Theranostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Experts’ Opinion
5. Radiopharmaceutical Theranostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Cancer
5.1.2 Rising Application in Treatment of Cardiovascular Disorders
5.2 Market Restraints
5.2.1 Regulatory Challenges for Approval of Radiopharmaceutical Theranostics
5.3 Market Opportunities
5.3.1 Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies
5.4 Future Trends
5.4.1 Radiopharmaceutical Theranostics in Nuclear Medicine
5.5 Impact Analysis
6. North America Radiopharmaceutical Theranostics Market Analysis
6.1 North America Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis
6.1.1 Market Positioning of Key Players in Radiopharmaceutical Theranostics Market
6.1.1.1 GE HealthCare Technologies Inc
6.1.1.2 Curium
7. North America Radiopharmaceutical Theranostics Market Analysis – by Product Type
7.1 Overview
7.1.1 Alpha Emitters
7.1.1.1 Overview
7.1.1.2 Alpha Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
7.1.2 Beta Emitters
7.1.2.1 Overview
7.1.2.2 Beta Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
7.1.3 Positron Emission Tomography (PET) Tracers
7.1.3.1 Overview
7.1.3.2 Positron Emission Tomography (PET) Tracers: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Radiopharmaceutical Theranostics Market Analysis – by Radioisotope
8.1 Overview
8.1.1 Technetium-99
8.1.1.1 Overview
8.1.1.2 Technetium-99: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.2 Gallium-68
8.1.2.1 Overview
8.1.2.2 Gallium-68: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.3 Iodine-131
8.1.3.1 Overview
8.1.3.2 Iodine-131: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.4 Iodine-123
8.1.4.1 Overview
8.1.4.2 Iodine-123: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.5 Fluorine-18 (18F)
8.1.5.1 Overview
8.1.5.2 Fluorine-18 (18F): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.6 Yttrium-90 (Y-90)
8.1.6.1 Overview
8.1.6.2 Yttrium-90 (Y-90): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.7 Lutetium (Lu) 177
8.1.7.1 Overview
8.1.7.2 Lutetium (Lu) 177: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.8 Copper (Cu) 67
8.1.8.1 Overview
8.1.8.2 Copper (Cu) 67: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.9 Copper (Cu) 64
8.1.9.1 Overview
8.1.9.2 Copper (Cu) 64: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
8.1.10 Others
8.1.10.1 Overview
8.1.10.2 Others: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Radiopharmaceutical Theranostics Market Analysis – by Source
9.1 Overview
9.1.1 Nuclear Reactors
9.1.1.1 Overview
9.1.1.2 Nuclear Reactors: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
9.1.2 Cyclotrons
9.1.2.1 Overview
9.1.2.2 Cyclotrons: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
10. North America Radiopharmaceutical Theranostics Market Analysis – by Application
10.1 Overview
10.1.1 Targeted Therapeutic (Rx)
10.1.1.1 Overview
10.1.1.2 Targeted Therapeutics (Rx): North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2 Companion Diagnostic (CDx)
10.1.2.1 Overview
10.1.2.2 Companion Diagnostics (CDx): North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
11. North America Radiopharmaceutical Theranostics Market Analysis – by Indication
11.1 Overview
11.1.1 Oncology
11.1.1.1 Overview
11.1.1.2 Oncology: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2 Neurology
11.1.2.1 Overview
11.1.2.2 Neurology: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3 Cardiology
11.1.3.1 Overview
11.1.3.2 Cardiology: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.4 Others
11.1.4.1 Overview
11.1.4.2 Others: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
12. North America Radiopharmaceutical Theranostics Market Analysis – by End User
12.1 Overview
12.1.1 Hospitals
12.1.1.1 Overview
12.1.1.2 Hospitals: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
12.1.2 Diagnostic Imaging Centers
12.1.2.1 Overview
12.1.2.2 Diagnostic Imaging Centers: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3 Academic & Research Institutes
12.1.3.1 Overview
12.1.3.2 Academic & Research Institutes: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
12.1.4 Others
12.1.4.1 Overview
12.1.4.2 Others: North America Radiopharmaceutical Theranostics Market Revenue and Forecasts to 2028 (US$ Million)
13. North America Radiopharmaceutical Theranostics Market
13.1 Overview
13.1.1 North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2 North America: Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)
13.1.3 North America: Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)
13.1.4 North America: Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)0
13.1.5 North America: Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)0
13.1.6 North America: Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)1
13.1.7 North America: Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)1
13.1.7.1 United States: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)3
13.1.7.1.1 Overview3
13.1.7.1.2 United States Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)4
13.1.7.1.3 United States Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)5
13.1.7.1.4 United States Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)6
13.1.7.1.5 United States Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)7
13.1.7.1.6 United States Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)7
13.1.7.1.7 United States Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)8
13.1.7.1.8 United States Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)8
13.1.7.2 Canada: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)9
13.1.7.2.1 Overview9
13.1.7.2.2 Canada Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)0
13.1.7.2.3 Canada Radiopharmaceutical Theranostics Market, by Product type, 2019–2028 (US$ Million)1
13.1.7.2.4 Canada Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)2
13.1.7.2.5 Canada Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)3
13.1.7.2.6 Canada Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)3
13.1.7.2.7 Canada Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)4
13.1.7.2.8 Canada Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)4
13.1.7.3 Mexico: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)5
13.1.7.3.1 Overview5
13.1.7.3.2 Mexico Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)6
13.1.7.3.3 Mexico Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)7
13.1.7.3.4 Mexico Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)8
13.1.7.3.5 Mexico Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)9
13.1.7.3.6 Mexico Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)9
13.1.7.3.7 Mexico Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)0
13.1.7.3.8 Mexico Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)1
14. North America Radiopharmaceutical Theranostics Market: Impact Assessment of COVID-19 Pandemic2
14.1 Impact Analysis of COVID-19 Pandemic on North America Radiopharmaceutical Theranostics Market2
15. North America Radiopharmaceutical Theranostics Market – Industry Landscape5
15.1 Overview5
15.2 Growth Strategies in North America Radiopharmaceutical Theranostics Market (%)6
15.3 Organic Developments7
15.3.1 Overview7
15.4 Inorganic Developments1
15.4.1 Overview1
16. Company Profiles5
16.1 Bayer AG5
16.1.1 Key Facts5
16.1.2 Business Description5
16.1.3 Products and Services6
16.1.4 Financial Overview7
16.1.5 SWOT Analysis0
16.1.6 Key Developments1
16.2 GE HealthCare Technologies Inc2
16.2.1 Key Facts2
16.2.2 Business Description2
16.2.3 Products and Services3
16.2.4 Financial Overview4
16.2.5 SWOT Analysis6
16.2.6 Key Developments7
16.3 Curium9
16.3.1 Key Facts9
16.3.2 Business Description9
16.3.3 Products and Services0
16.3.4 Financial Overview0
16.3.5 SWOT Analysis1
16.3.6 Key Developments2
16.4 Lantheus Medical Imaging, Inc.3
16.4.1 Key Facts3
16.4.2 Business Description3
16.4.3 Products and Services4
16.4.4 Financial Overview4
16.4.5 SWOT Analysis6
16.4.6 Key Developments7
16.5 Telix Pharmaceuticals Ltd.8
16.5.1 Key Facts8
16.5.2 Business Description8
16.5.3 Products and Services9
16.5.4 Financial Overview9
16.5.5 SWOT Analysis1
16.5.6 Key Developments2
16.6 Cardinal Health Inc3
16.6.1 Key Facts3
16.6.2 Business Description3
16.6.3 Products and Services4
16.6.4 Financial Overview4
16.6.5 SWOT Analysis6
16.6.6 Key Developments7
16.7 Advanced Accelerator Applications S.A.8
16.7.1 Key Facts8
16.7.2 Business Description8
16.7.3 Products and Services9
16.7.4 Financial Overview9
16.7.5 SWOT Analysis0
16.7.6 Key Developments1
16.8 Jubilant Radiopharma2
16.8.1 Key Facts2
16.8.2 Business Description2
16.8.3 Products and Services3
16.8.4 Financial Overview3
16.8.5 SWOT Analysis4
16.8.6 Key Developments5
16.9 Theragnostics6
16.9.1 Key Facts6
16.9.2 Business Description6
16.9.3 Products and Services6
16.9.4 Financial Overview6
16.9.5 SWOT Analysis7
16.9.6 Key Developments8
16.10 NuView Life Sciences9
16.10.1 Key Facts9
16.10.2 Business Description9
16.10.3 Products and Services9
16.10.4 Financial Overview0
16.10.5 SWOT Analysis0
16.10.6 Key Developments1
17. Appendix2
17.1 About The Insight Partners2
17.2 Glossary of Terms3
LIST OF TABLES
Table 1. North America Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 6. North America Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. United States Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)3
Table 8. United States Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)4
Table 9. United States Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)5
Table 10. United States Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)5
Table 11. United States Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)6
Table 12. United States Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)6
Table 13. Canada Radiopharmaceutical Theranostics Market, by Product type – Revenue and Forecast to 2028 (US$ Million)9
Table 14. Canada Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)0
Table 15. Canada Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)1
Table 16. Canada Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)1
Table 17. Canada Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)2
Table 18. Canada Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)2
Table 19. Mexico Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)5
Table 20. Mexico Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)6
Table 21. Mexico Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)7
Table 22. Mexico Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)7
Table 23. Mexico Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)8
Table 24. Mexico Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)9
Table 25. Organic Developments in the North America Radiopharmaceutical Theranostics Market5
Table 26. Inorganic Developments in the North America Radiopharmaceutical Theranostics Market9
Table 27. Glossary of Terms0
LIST OF FIGURES
Figure 1. Radiopharmaceutical Theranostics Market Segmentation
Figure 2. Radiopharmaceutical Theranostics Market Segmentation, by Region
Figure 3. North America Radiopharmaceutical Theranostics Market Overview
Figure 4. Positron Emission Tomography (PET) Tracers Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market
Figure 5. U.S. to Show Significant Growth in Radiopharmaceutical Theranostics Market During Forecast Period
Figure 6. North America Radiopharmaceutical Theranostics Market – Leading Country Markets (US$ Million)
Figure 7. North America Radiopharmaceutical Theranostics Market, Industry Landscape
Figure 8. North America PEST Analysis
Figure 9. Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints
Figure 10. North America Radiopharmaceutical Theranostics Market – Revenue Forecast and Analysis – 2020–2028
Figure 11. North America Radiopharmaceutical Theranostics Market, by Product Type, 2021 & 2028 (%)
Figure 12. Alpha Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Beta Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Positron Emission Tomography (PET) Tracers: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)
Figure 16. Technetium-99: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Gallium-68: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Iodine-131: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Iodine-123: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Fluorine-18 (18F): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Yttrium-90 (Y-90): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Lutetium (Lu) 177: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Copper (Cu) 67: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Copper (Cu) 64: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)
Figure 27. Nuclear Reactors Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Cyclotrons Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. North America Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)
Figure 30. Targeted Therapeutics (Rx) Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Companion Diagnostics (CDx) Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. North America Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)
Figure 33. Oncology: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Neurology Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Cardiology: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Others Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. North America Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)
Figure 38. Hospitals Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Diagnostic Imaging Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 40. Academic & Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)
Figure 41. Others Market Revenue and Forecasts to 2028 (US$ Million)
Figure 42. North America Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 43. North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. North America Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)0
Figure 45. United States Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)2
Figure 46. Canada Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)8
Figure 47. Mexico Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)4
Figure 48. Impact of COVID-19 Pandemic on North America Markets2
Figure 49. Growth Strategies in North America Radiopharmaceutical Theranostics Market (%)4
The List of Companies - North America Radiopharmaceutical Theranostics Market
- Bayer AG
- GE HealthCare Technologies Inc
- Curium
- Lantheus Medical Imaging, Inc.
- Telix Pharmaceuticals Ltd.
- Cardinal Health Inc
- Advanced Accelerator Applications S.A.
- Jubilant Radiopharma
- Theragnostics
- NuView Life Sciences
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Radiopharmaceutical Theranostics Market
Mar 2023
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Mar 2023
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Mar 2023
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Mar 2023
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Mar 2023
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Mar 2023
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2023
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
Mar 2023
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For